10x Genomics Inc. Optimization Slides, Reagent Kits, and Reagent Delivery Methods

Closed Pre-Solicitation Posted

Solicitation number
75N95024Q00448
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services' National Institutes of Health, intends to negotiate and issue a 12-month extension to an existing indefinite-delivery, indefinite-quantity (IDIQ) contract with 10X Genomics, Inc. to continue providing 10X Genomics-manufactured optimization slides, reagent kits, and reagent delivery methods. These biological technologies are used in NINDS research projects to map gene expression, transcription, and profiling for neurological diseases. Responses to this pre-solicitation notice must be received by 4:00 PM ET on July 31, 2024 and include the contractor's Unique Entity Identifier, Taxpayer Identification Number, and business size certification.

This proposed contract modification is classified under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. There is no set-aside designation for this procurement. The existing IDIQ contract (75N95023D00018) was awarded as a result of a previous solicitation, and the proposed modification would not result in any other changes to the contract. No award value or budget range information is provided in the pre-solicitation notice.

Notice text

The purpose of this acquisition is to continue providing 10X Genomics Inc.-manufactured optimization slides, reagent kits, and reagent delivery methods to the laboratories of the National Institute of Neurological Disorders and Stroke (NINDS).  Related previous and continuing research projects being conducted by NINDS laboratories have utilized the 10X Genomics Inc. reagent kits, optimization slides and other consumables in tandem with an existing 10X Genomics Inc. Chromium System. To maintain the integrity of the research data previously generated, the same reagent kits, optimization slides and consumables must be used for the ongoing and planned, follow-on research projects. These biological technologies are used to map gene expression, transcription, and profiling for neurological diseases such as Psychosis, Multiple Sclerosis, Undiagnosed neuroinflammatory diseases, and many other neurological and brain disorders. Please see the attached Presolicitation Notice for additional information.

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
DNA Sequencing Service Durham, North Carolina 27709, United States · NAICS 541714 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent - Illumina MiSeq i100 series instruments Bethesda, Maryland 20892, United States · NAICS 334516 NIH Clinical Center No set-aside
Combined Synopsis Solicitation (competitive) NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
6640--Next Generation Sequencing (NGS) Reagent Kits Iowa City VA Health Care System Iowa City, Iowa 52246, United States · NAICS 334516 Veterans Integrated Service Network 23 No set-aside
Preclinical Medications Discovery and Abuse Liability Testing for NIDA Bethesda, Maryland, United States · NAICS 541715 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors